BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24561361)

  • 1. Evaluation of mutation profiling by matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry in fine needle aspirations from papillary thyroid cancer.
    Woo HI; Kim SW; Ki CS; Shin JH; Oh YL; Kim JW; Chung JH
    Clin Chem Lab Med; 2014 Jul; 52(7):e139-42. PubMed ID: 24561361
    [No Abstract]   [Full Text] [Related]  

  • 2. Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions.
    Pagni F; De Sio G; Garancini M; Scardilli M; Chinello C; Smith AJ; Bono F; Leni D; Magni F
    Proteomics; 2016 Jun; 16(11-12):1775-84. PubMed ID: 27029406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.
    Zhao H; Zhang ZH; Zhou B; Xiao T; Pan QJ; Guo HQ
    Diagn Cytopathol; 2015 Oct; 43(10):786-90. PubMed ID: 26152656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of fine needle aspiration BRAF(V600E) mutation analysis in papillary thyroid cancer: a systematic review and meta-analysis.
    Fnais N; Soobiah C; Al-Qahtani K; Hamid JS; Perrier L; Straus SE; Tricco AC
    Hum Pathol; 2015 Oct; 46(10):1443-54. PubMed ID: 26232865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allele-specific PCR with competitive probe blocking for sensitive and specific detection of BRAF V600E in thyroid fine-needle aspiration specimens.
    Smith GD; Zhou L; Rowe LR; Jarboe EA; Collins BT; Bentz JS; Wittwer CT; Chadwick BE
    Acta Cytol; 2011; 55(6):576-83. PubMed ID: 22156469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging mass spectrometry in papillary thyroid carcinoma for the identification and validation of biomarker proteins.
    Min KW; Bang JY; Kim KP; Kim WS; Lee SH; Shanta SR; Lee JH; Hong JH; Lim SD; Yoo YB; Na CH
    J Korean Med Sci; 2014 Jul; 29(7):934-40. PubMed ID: 25045225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of cellularity, genomic DNA yields, and technical platforms for BRAF mutational testing in thyroid fine-needle aspirate samples.
    Dyhdalo K; Macnamara S; Brainard J; Underwood D; Tubbs R; Yang B
    Cancer Cytopathol; 2014 Feb; 122(2):114-22. PubMed ID: 24150898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison Between Real-Time PCR and Pyrosequencing for Detection of BRAF V600E Mutation in Thyroid Fine-Needle Aspirates.
    Kim WY; Kim H; Hwang TS; Oh SY
    Appl Immunohistochem Mol Morphol; 2017; 25(5):358-365. PubMed ID: 26657877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomorphological factors and BRAF mutation predicting risk of lymph node metastasis in preoperative liquid-based fine needle aspirations of papillary thyroid carcinoma.
    Chung SY; Lee JS; Lee H; Park SH; Kim SJ; Ryu HS
    Acta Cytol; 2013; 57(3):252-8. PubMed ID: 23636013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrimination of papillary thyroid cancer from non-cancerous thyroid tissue based on lipid profiling by mass spectrometry imaging.
    Wojakowska A; Cole LM; Chekan M; Bednarczyk K; Maksymiak M; Oczko-Wojciechowska M; Jarząb B; Clench MR; Polańska J; Pietrowska M; Widlak P
    Endokrynol Pol; 2018; 69(1):2-8. PubMed ID: 29492952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysis.
    Borrelli N; Ugolini C; Giannini R; Antonelli A; Giordano M; Sensi E; Torregrossa L; Fallahi P; Miccoli P; Basolo F
    Cancer Cytopathol; 2016 May; 124(5):340-9. PubMed ID: 26749005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of the repeated examination of BRAF V600E mutation status in diagnostics of papillary thyroid cancer.
    Beiša A; Beiša V; Stoškus M; Ostanevičiūtė E; Griškevičius L; Strupas K
    Endokrynol Pol; 2016; 67(1):35-40. PubMed ID: 26884113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic metastasis of papillary thyroid carcinoma preoperatively diagnosed by endoscopic ultrasound-guided fine-needle aspiration biopsy: a case report with review of literatures.
    Murakami Y; Shimura T; Okada R; Kofunato Y; Ishigame T; Yashima R; Nakano K; Suzuki S; Takenoshita S
    Clin J Gastroenterol; 2018 Dec; 11(6):521-529. PubMed ID: 29948817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRAF mutation analysis of fine-needle aspiration biopsies of papillary thyroid carcinoma: impact on diagnosis and prognosis.
    Colanta A; Lin O; Tafe L; Ghossein R; Nafa K; Mitchell T; Ladanyi M; Arcila M
    Acta Cytol; 2011; 55(6):563-9. PubMed ID: 22156467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic study of thyroid tumors reveals frequent up-regulation of the Ca2+ -binding protein S100A6 in papillary thyroid carcinoma.
    Sofiadis A; Dinets A; Orre LM; Branca RM; Juhlin CC; Foukakis T; Wallin G; Höög A; Hulchiy M; Zedenius J; Larsson C; Lehtiö J
    Thyroid; 2010 Oct; 20(10):1067-76. PubMed ID: 20629554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An alternative approach in endocrine pathology research: MALDI-IMS in papillary thyroid carcinoma.
    Mainini V; Pagni F; Garancini M; Giardini V; De Sio G; Cusi C; Arosio C; Roversi G; Chinello C; Caria P; Vanni R; Magni F
    Endocr Pathol; 2013 Dec; 24(4):250-3. PubMed ID: 24142502
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical Implication of Highly Sensitive Detection of the BRAFV600E Mutation in Fine-Needle Aspirations According to the Thyroid Bethesda System in Patients With Conventional Papillary Thyroid Carcinoma.
    Seo JY; Choi JR; Moon HJ; Kim EK; Han KH; Kim H; Kwak JY
    Ann Otol Rhinol Laryngol; 2015 May; 124(5):392-9. PubMed ID: 25404749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine-needle aspiration diagnoses of noninvasive follicular variant of papillary thyroid carcinoma.
    Howitt BE; Chang S; Eszlinger M; Paschke R; Drage MG; Krane JF; Barletta JA
    Am J Clin Pathol; 2015 Dec; 144(6):850-7. PubMed ID: 26572991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAF p.Val600Glu (V600E) mutation detection in thyroid fine needle aspiration cell block samples: a feasibility study.
    Leslie C; Grieu-Iacopetta F; Richter A; Platten M; Murray J; Frost FA; Amanuel B; Kumarasinghe MP
    Pathology; 2015 Aug; 47(5):432-8. PubMed ID: 26154146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis.
    Marchetti I; Iervasi G; Mazzanti CM; Lessi F; Tomei S; Naccarato AG; Aretini P; Alberti B; Di Coscio G; Bevilacqua G
    Thyroid; 2012 Mar; 22(3):292-8. PubMed ID: 22181337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.